Hematuria screening for bladder cancer.

Cytological screening for cancer of the bladder.

Home screening for hematuria: results of a multiclinic study.

Screening for bladder cancer in individuals with spinal cord injury.

MicroRNAs in biofluids are novel tools for bladder cancer screening.

New opportunities for screening and early detection of bladder cancer.

Bladder cancer screening in aluminum smelter workers.

UBE2C cell-free RNA in urine can discriminate between bladder cancer and hematuria.

Gender disparities in hematuria evaluation and bladder cancer diagnosis: a population based analysis.

A rare cyclic recurrent hematuria case; bladder endometriosis.

Metastasis to the bladder from pancreatic adenocarcinoma presenting with hematuria.

Screening candidate genes associated with bladder cancer using DNA microarray.

Bladder Preservation for Muscle Invasive Bladder Cancer.

Hematuria.

Immunotherapy for bladder cancer.

Screening for bladder cancer with urinary tumor markers in chemical workers with exposure to aromatic amines.

Clinical utility of urinary soluble Fas in screening for bladder cancer.

Evaluation of DNA flow cytometry as a screening test for bladder cancer.

ICUD consensus.

Bladder cancer after radiotherapy for prostate cancer.

Liquid biopsies for bladder cancer.

Emerging immunotherapies for bladder cancer.

Intravesical therapy for bladder cancer.

Radical cystectomy for bladder cancer.

Maximum bladder volume as surrogate screening test for detrusor overactivity.

Suggest Documents

Cytological screening for cancer of the bladder.

Home screening for hematuria: results of a multiclinic study.

Screening for bladder cancer in individuals with spinal cord injury.

MicroRNAs in biofluids are novel tools for bladder cancer screening.

New opportunities for screening and early detection of bladder cancer.

Bladder cancer screening in aluminum smelter workers.

UBE2C cell-free RNA in urine can discriminate between bladder cancer and hematuria.

Gender disparities in hematuria evaluation and bladder cancer diagnosis: a population based analysis.

A rare cyclic recurrent hematuria case; bladder endometriosis.

Metastasis to the bladder from pancreatic adenocarcinoma presenting with hematuria.

Screening candidate genes associated with bladder cancer using DNA microarray.

Bladder Preservation for Muscle Invasive Bladder Cancer.

Hematuria.

Immunotherapy for bladder cancer.

Screening for bladder cancer with urinary tumor markers in chemical workers with exposure to aromatic amines.

Clinical utility of urinary soluble Fas in screening for bladder cancer.

Evaluation of DNA flow cytometry as a screening test for bladder cancer.

ICUD consensus.

Bladder cancer after radiotherapy for prostate cancer.

Liquid biopsies for bladder cancer.

Emerging immunotherapies for bladder cancer.

Intravesical therapy for bladder cancer.

Radical cystectomy for bladder cancer.

Maximum bladder volume as surrogate screening test for detrusor overactivity.

Hematuria screening for bladder cancer.

Recommend Documents

Follow Us